News & Press: Breaking News

The University of Pennsylvania Receives Breakthrough Therapy Designation from the FDA

Tuesday, July 15, 2014  
Posted by: ISCT Administrator
Share |
The University of Pennsylvania has received Breakthrough Therapy Designation from the FDA. For more information, CLICK HERE.

The FDA has previously granted Breakthrough Therapy to only four other biologic agents and this is the first personalized cell therapy for cancer to obtain it.  From October through June 30, the FDA received 20 applications and only 3 were approved, the previous year, 10 of 11 applications were not approved.

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.